Last update 16 May 2024
TBX-3400
Last update 16 May 2024
Overview
Basic Info
Drug Type Cell therapy |
Synonyms autologous human peripheral blood mononuclear cells incubated ex vivo with protein TBX-4000 (Tat-MYC) |
Target- |
Mechanism Cell replacements, Immunologic cytotoxicity, Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Related
2
Clinical Trials associated with TBX-3400A Phase 1/2 Multi-Center Dose-Escalation Study of the Safety, Tolerability and Early Efficacy of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies
A Phase 1 Multi-Center Dose-Escalation Study of the Safety, Tolerability and Early Efficacy of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors
100 Clinical Results associated with TBX-3400
Login to view more data
100 Translational Medicine associated with TBX-3400
Login to view more data
100 Patents (Medical) associated with TBX-3400
Login to view more data
100 Deals associated with TBX-3400
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Melanoma | Phase 2 | US | 22 Jul 2022 | |
| Refractory Cancer | Phase 2 | IL | 25 Jan 2021 | |
| Refractory Cancer | Phase 2 | US | 25 Jan 2021 | |
| Solid tumor | Phase 2 | IL | 25 Jan 2021 | |
| Solid tumor | Phase 2 | US | 25 Jan 2021 | |
| Malignant melanoma stage IV | Phase 1 | US | 02 Jun 2019 | |
| Human Papillomavirus Infection | Preclinical | US | - | |
| Hepatitis B | Discovery | TH | 02 Mar 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free